Therapeutic efficacy of bovine ultra-long CDR H3 antibody against BVDV in challenged BALB/c mouse model
< 0.05). These results collectively underscore the potential of ultralong CDR H3 antibody platforms as viable candidates for novel BVDV immunotherapeutics and vaccine development.
Authors
- Shujun Zhang
- Fuxiang Bao (ORCID: https://orcid.org/0000-0003-4807-6277)
- Hao Wang (ORCID: https://orcid.org/0000-0001-6881-9977)
- Gege Rile
- Qihuan Zhao
- Jingsi Mei
- Bo Wang
- Na Qi
Institutions
- Inner Mongolia Agricultural University (CN)
- Miller Group (Canada) (CA)
- Ministry of Agriculture (ID)
- Ministry of Agriculture and Rural Affairs (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-04-07
- DOI
- https://doi.org/10.3389/fimmu.2026.1805322
- Primary Topic
- Animal Disease Management and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00